Assembly Biosciences, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$2.40 | -$2.06 | -$2.23 |
Q2 2024 | 1 | -$2.48 | -$2.13 | -$2.30 |
Q3 2024 | 1 | -$2.31 | -$1.73 | -$2.02 |
Q1 2025 | 1 | -$2.47 | -$1.95 | -$2.21 |
Q2 2025 | 1 | -$1.97 | -$1.69 | -$1.83 |
Q3 2025 | 1 | -$2.00 | -$1.72 | -$1.86 |
Q4 2025 | 1 | -$2.00 | -$1.72 | -$1.86 |
Q1 2026 | 1 | -$1.96 | -$1.68 | -$1.82 |
Q2 2026 | 1 | -$2.51 | -$2.15 | -$2.33 |
Q3 2026 | 1 | -$2.98 | -$2.56 | -$2.77 |
Q4 2026 | 1 | -$3.03 | -$2.61 | -$2.82 |
Assembly Biosciences, Inc. Earnings Date And Information
Assembly Biosciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-1.51 earnings per share for the quarter, topping analysts' consensus estimates of $-2.02 by $0.51. The company had revenue of 6.85 M for the quarter and had revenue of 7.16 M for the year. Assembly Biosciences, Inc. has generated $-13 earnings per share over the last year ($-13.38 diluted earnings per share) and currently has a price-to-earnings ratio of -2.33. Assembly Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Assembly Biosciences, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$2.02 | -$1.51 | 0.51 | $5.77 M | $6.85 M |
08/08/2024 | Q2 2024 | -$2.96 | -$1.98 | 0.98 | $6.00 M | $8.53 M |
05/08/2024 | Q1 2024 | -$2.74 | -$1.66 | 1.08 | $5.79 M | |
12/29/2023 | Q4 2023 | -$2.00 | $7.16 M | |||
11/08/2023 | Q3 2023 | -$2.76 | -$3.29 | -0.53 | $0 | |
08/09/2023 | Q2 2023 | -$3.48 | -$3.88 | -0.4 | $0 | |
05/04/2023 | Q1 2023 | -$4.44 | -$4.31 | 0.13 | $0 | |
03/22/2023 | Q4 2022 | -$6.72 | -$5.32 | 1.4 | $0 | |
11/08/2022 | Q3 2022 | -$5.64 | -$0.47 | 5.17 | $0 | |
08/09/2022 | Q2 2022 | -$5.88 | -$0.50 | 5.38 | $0 | |
05/12/2022 | Q1 2022 | -$5.88 | -$0.48 | 5.4 | $0 | |
03/11/2022 | Q4 2021 | -$1.34 | $0 | |||
11/04/2021 | Q3 2021 | -$6.60 | -$0.41 | 6.19 | $6.25 M | |
08/05/2021 | Q2 2021 | -$7.68 | -$0.55 | 7.13 | $1.63 M | $0 |
05/06/2021 | Q1 2021 | -$9.48 | -$0.69 | 8.79 | $0 | |
02/25/2021 | Q4 2020 | -$10.80 | -$0.99 | 9.81 | $1.04 M | |
11/05/2020 | Q3 2020 | -$9.36 | -$0.09 | 9.27 | $6.44 M | $34.61 M |
08/05/2020 | Q2 2020 | -$0.36 | $0.21 | 0.57 | $30.54 M | $39.38 M |
05/08/2020 | Q1 2020 | -$0.76 | $4.08 M | |||
03/04/2020 | Q4 2019 | -$12.12 | -$0.77 | 11.35 | $4.77 M |
Assembly Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Assembly Biosciences, Inc.'s earnings date?
Assembly Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
Did Assembly Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Assembly Biosciences, Inc. (:ASMB) reported $-1.51 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.02 by $0.51.
-
How can I listen to Assembly Biosciences, Inc.'s earnings conference call?
The conference call for Assembly Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Assembly Biosciences, Inc.'s conference call transcript?
The conference call transcript for Assembly Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Assembly Biosciences, Inc. generate each year?
Assembly Biosciences, Inc. (:ASMB) has a recorded annual revenue of $7.16 M.
-
How much profit does Assembly Biosciences, Inc. generate each year?
Assembly Biosciences, Inc. (:ASMB) has a recorded net income of $7.16 M. Assembly Biosciences, Inc. has generated $-13.38 earnings per share over the last four quarters.
-
What is Assembly Biosciences, Inc.'s price-to-earnings ratio?
Assembly Biosciences, Inc. (:ASMB) has a price-to-earnings ratio of -2.33 and price/earnings-to-growth ratio is -0.06.